INTERCEPT PHARMACEUTICALS, INC. Insider Trading for November 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. for November 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 30 2015 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | See Remarks | Sell | S | 182.97 | 1,150 | 210,409 | 12,428 | 13.6 K to 12.4 K (-8.47 %) |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 183.62 | 1,750 | 321,335 | 1,750 | |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 650 | 0 | 10,542 | 9.9 K to 10.5 K (+6.57 %) |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 183.62 | 1,750 | 321,335 | 1,750 | |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Grant | A | 0.00 | 650 | 0 | 1,259 | 609 to 1.3 K (+106.73 %) |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Option Exercise | A | 183.62 | 1,750 | 321,335 | 1,750 | |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Grant | A | 0.00 | 650 | 0 | 8,871 | 8.2 K to 8.9 K (+7.91 %) |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | Benatti Luca | Director | Option Exercise | A | 183.62 | 1,750 | 321,335 | 1,750 | |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | Benatti Luca | Director | Grant | A | 0.00 | 650 | 0 | 1,942 | 1.3 K to 1.9 K (+50.31 %) |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Option Exercise | A | 183.62 | 1,750 | 321,335 | 1,750 | |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Grant | A | 0.00 | 650 | 0 | 2,816 | 2.2 K to 2.8 K (+30.01 %) |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Option Exercise | A | 183.62 | 1,750 | 321,335 | 1,750 | |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 650 | 0 | 1,102 | 452 to 1.1 K (+143.81 %) |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Option Exercise | A | 183.62 | 3,500 | 642,670 | 3,500 | |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Grant | A | 0.00 | 1,300 | 0 | 1,300 | 0 to 1.3 K |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Option Exercise | A | 183.62 | 3,500 | 642,670 | 3,500 | |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,300 | 0 | 1,300 | 0 to 1.3 K |
Nov 23 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Option Exercise | M | 9.82 | 973 | 9,557 | 974 | |
Nov 23 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Sell | S | 167.00 | 973 | 162,491 | 962 | 1.9 K to 962 (-50.28 %) |
Nov 23 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Buy | M | 9.82 | 973 | 9,557 | 1,935 | 962 to 1.9 K (+101.14 %) |
Nov 18 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 3,500 | 30,333 | 3,500 | |
Nov 18 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 179.49 | 1,500 | 269,235 | 28,395 | 29.9 K to 28.4 K (-5.02 %) |
Nov 18 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 178.00 | 2,764 | 492,002 | 29,895 | 32.7 K to 29.9 K (-8.46 %) |
Nov 18 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 3,500 | 30,333 | 32,659 | 29.2 K to 32.7 K (+12.00 %) |
Nov 12 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Option Exercise | M | 21.50 | 1,000 | 21,500 | 5,972 | |
Nov 12 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 198.25 | 1,000 | 198,250 | 2,166 | 3.2 K to 2.2 K (-31.59 %) |
Nov 12 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Buy | M | 21.50 | 1,000 | 21,500 | 3,166 | 2.2 K to 3.2 K (+46.17 %) |
Nov 12 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 3,500 | 30,333 | 7,000 | |
Nov 12 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 204.15 | 3,500 | 714,525 | 29,159 | 32.7 K to 29.2 K (-10.72 %) |
Nov 12 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 3,500 | 30,333 | 32,659 | 29.2 K to 32.7 K (+12.00 %) |
Nov 04 2015 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 160.24 | 125 | 20,029 | 8,218 | 8.3 K to 8.2 K (-1.50 %) |